Nanotechnology-driven platforms for extracellular vesicle analysis in tumor immunotherapy

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Cancer immunotherapy has advanced, but limited patient response necessitates new biomarkers.
• Liquid biopsy offers a non-invasive approach for real-time cancer patient monitoring.
• Extracellular vesicles (EVs) contain molecules relevant to tumor progression and immune response.

Purpose of the Study:

• To review the role of EVs in the tumor immune microenvironment.
• To discuss the advantages of nanotechnology for EV detection.
• To summarize the clinical significance of EVs in monitoring cancer immunotherapy.

Main Methods:

• Review of current literature on EVs and cancer immunotherapy.
• Analysis of conventional and nanotechnology-based EV detection methods.
• Discussion of EVs as biomarkers in the tumor immune microenvironment.

Main Results:

• EVs are crucial for intercellular communication within the tumor immune microenvironment.
• Nanotechnology provides superior detection capabilities for EVs compared to conventional methods.
• EVs show significant potential as molecular markers for immunotherapy efficacy.

Conclusions:

• EVs are vital for understanding and monitoring cancer immunotherapy.
• Nanotechnology-enhanced EV detection can improve prediction of treatment response.
• EVs hold promise for personalized cancer treatment strategies.